“Our on-time-in-full delivery was 30%. In the beer industry, it’s around 99%. That was a big shock.” When Gijs Vissers joined the pharmaceutical industry, he saw that supply chain operations were often driven by fragmented processes, minimal performance tracking, and
This guest editorial is by Kishore Hotha, PhD, MBA, President, Dr. Hotha’s Life Sciences LLC Chemistry can fail in drug development. Unexpected impurity profiles, scale-up variability, conjugation instability, containment exceedances—these are real and consequential. Anyone who has led a CMC
Tony Watson, Director of Procurement at Accord Healthcare, believes relationships are everything: “We spend our entire careers working on this network, but it can deliver so much more. If I could do one thing with CDMOs and our business support
“When we go to an external partner, we need to show up as one single aligned organization. If we’re not aligned internally, the CMO ends up becoming the referee.” In pharmaceutical manufacturing, the quality of a CDMO partnership is rarely
